Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Article

Medical Treatment of Diabetes Mellitus

Mario Skugor, MD
Cleveland Clinic Journal of Medicine July 2017, 84 (7 suppl 1) S57-S61; DOI: https://doi.org/10.3949/ccjm.84.s1.07
Mario Skugor
Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    Glycemic treatments by therapeutic category

    Insulin sensitizers
    Biguanide: metfomin (Fortamet, Glucophage, Glumetza, Riomet)
    Thiazolidinedione: pioglitazone (Actos), rosiglitazone (Avandia)

    Insulin secretagogues
    Sulfonylureas: chlorpropamide (Diabinese), glimepiride (Amaryl), glipizide (Glucotrol), glyburide (Micronase, Glynase)
    Glinides: repaglinide (Prandin), nateglinide (Starlix)

    Alpha-glucosidase inhibitors
    Acarbose (Precose), miglitol (Glyset), voglibose

    Incretin-based therapies
    Glucagon-like peptide-1 agonists: albiglutide (Tanzeum), dulaglutide (Trulicity), exenatide (Bydureon, Byetta), liraglutide (Saxenda, Victoza), lixisenatide (Adlyxin)
    Dipeptidyl peptidase-4 inhibitors: alogliptin (Nesina), linagliptin (Tradjenta), saxagliptin (Onglyza), sitagliptin (Januvia)

    Sodium-glucose transporter-2 inhibitors
    Canagliflozin (Invokana), dapagliflozin (Farxiga), empagliflozin (Jardiance)

    Amylinomimetic
    Pramlintide (SymlinPen 120, SymlinPen 60)
    Dopamine agonist
    Bromocriptine (Cycloset)

    Insulin
    Rapid-acting
     Aspart insulin (Novolog)
     Glulisine insulin (Apidra)
     Lispro insulin (Humalog)
    Short-acting
     Regular insulin (HumuLIN R, HumuLIN R U-500 KwikPen,
     NovoLIN R, NovoLIN R ReliOn)
    Intermediate-acting
     Isophane insulin, NPH insulin (Humulin N, Novolin N)
    Long-acting
     Detemir insulin (Levemir)
     Glargine insulin (Basaglar KwikPen, Lantus, Lantus SoloStar, Toujeo SoloStar)
     Degludec insulin (Tresiba)
    Premixed
     Several types intermediate-acting and short-acting insulin combined are available
    • Based on information from the American Diabetes Association8 and Inzucchi et al.12

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 84 (7 suppl 1)
Cleveland Clinic Journal of Medicine
Vol. 84, Issue 7 suppl 1
1 Jul 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Medical Treatment of Diabetes Mellitus
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Medical Treatment of Diabetes Mellitus
Mario Skugor
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7 suppl 1) S57-S61; DOI: 10.3949/ccjm.84.s1.07

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Medical Treatment of Diabetes Mellitus
Mario Skugor
Cleveland Clinic Journal of Medicine Jul 2017, 84 (7 suppl 1) S57-S61; DOI: 10.3949/ccjm.84.s1.07
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • Measuring Glycemic Control
    • Glycemic Treatment
    • Initiation and Titration of Therapy
    • Summary
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A practical approach to the cholesterol guidelines and ASCVD prevention
  • New treatments for peripheral artery disease
  • Functional tricuspid regurgitation: Feasibility of transcatheter interventions
Show more Article

Similar Articles

Subjects

  • Diabetes
  • Drug Therapy
  • Endocrinology
  • Obesity

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire